Ralph Tiedt,Alan Buckler,Fred Harbinski,Sneha Sanghavi,Douglas Jeffery,Christopher Wilson
申请号：
US14388251
公开号：
US20150051210A1
申请日:
2013.04.01
申请国别(地区):
US
年份:
2015
代理人:
摘要：
The invention relates to pharmaceutical combination product comprising (i) a MET inhibitor and (ii) an FGFR inhibitor, or a pharmaceutical acceptable salt thereof, respectively, or a prodrug thereof, respectively, and at least one pharmaceutically acceptable carrier.
